GlassScriptPhysician profile
Lina Saadeh
NPI 1285065888
$302.98
in general payments reported to CMS, 2019-2025
10 companies · $103 in 2025
The $103 reported for 2025 was less than what a typical Pediatric Endocrinology provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $44.92 · 2022: $22.27 · 2023: $50.78 · 2024: $82.24 · 2025: $103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $236.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $235.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $44.92 | 2020 | |
| Insulet Corporation | $42.60 | 2024 | Omnipod |
| Xeris Pharmaceuticals, INC. | $42.52 | 2025 | Gvoke Hypopen |
| Abbott Laboratories | $37.18 | 2023-2024 | Freestyle Libre 3 |
| Dexcom, INC. | $37.04 | 2025 | Dexcom G6 Transmitter |
| Tandem Diabetes Care, INC. | $23.21 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Ascendis Pharma Endocrinology INC | $22.27 | 2022 | |
| Abbvie INC. | $21.60 | 2023 | Lupron Depot |
| Amphastar Pharmaceuticals, INC. | $18.24 | 2024 | |
| Novo Nordisk INC | $13.40 | 2023 | Sogroya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lina Saadeh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.